Cinemark's (CNK) "Outperform" Rating Reaffirmed at Barrington Research

Key Points

• Barrington Research reaffirmed its Outperform rating on Cinemark with a $36 price target, implying roughly a 24.8% upside from the prior close.
• Analyst consensus is a Moderate Buy (10 Buys, 4 Holds, 1 Sell) with an average price target of $33.23, reflecting generally positive but varied analyst views.
• In the latest quarter Cinemark reported a slight EPS miss (‑$0.06 vs. ‑$0.05 expected) while beating revenue at $643.1M (+18.9% YoY); the stock trades around $28.85 with a $3.37B market cap.

Cinemark (NYSE:CNK - Get Free Report)'s stock had its "outperform" rating restated by equities researchers at Barrington Research in a note issued to investors on Monday,Benzinga reports. They presently have a $36.00 target price on the stock. Barrington Research's target price would indicate a potential upside of 24.80% from the stock's previous close.

Other analysts also recently issued reports about the company. The Goldman Sachs Group restated a "sell" rating and issued a $22.00 price target on shares of Cinemark in a research note on Thursday, February 19th. Wells Fargo & Company increased their price objective on shares of Cinemark from $32.00 to $36.00 and gave the company an "overweight" rating in a research note on Thursday, April 9th. Wall Street Zen upgraded Cinemark from a "sell" rating to a "hold" rating in a research report on Saturday, February 21st. Moffett Nathanson upgraded Cinemark from a "neutral" rating to a "buy" rating and set a $30.00 target price on the stock in a report on Tuesday, January 20th. Finally, UBS Group raised Cinemark to a "buy" rating in a report on Tuesday, January 20th. Ten investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, Cinemark presently has an average rating of "Moderate Buy" and a consensus price target of $33.23.

Cinemark Trading Up 4.4%

Shares of Cinemark stock opened at $28.85 on Monday. The firm has a market cap of $3.37 billion, a price-to-earnings ratio of 25.60 and a beta of 1.03. Cinemark has a 52-week low of $21.60 and a 52-week high of $34.01. The company's 50-day simple moving average is $28.22 and its 200-day simple moving average is $26.42. The company has a quick ratio of 0.67, a current ratio of 0.71 and a debt-to-equity ratio of 4.81.

Cinemark (NYSE:CNK - Get Free Report) last announced its quarterly earnings data on Friday, May 1st. The company reported ($0.06) earnings per share for the quarter, missing analysts' consensus estimates of ($0.05) by ($0.01). Cinemark had a net margin of 5.31% and a return on equity of 41.31%. The business had revenue of $643.10 million during the quarter, compared to analysts' expectations of $632.74 million. Cinemark's revenue for the quarter was up 18.9% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.32) EPS. As a group, equities research analysts anticipate that Cinemark will post 2.14 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Melissa Thomas sold 7,944 shares of the company's stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $26.05, for a total transaction of $206,941.20. Following the sale, the executive vice president directly owned 159,416 shares of the company's stock, valued at approximately $4,152,786.80. This represents a 4.75% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 2.40% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC increased its stake in shares of Cinemark by 118.5% in the second quarter. EverSource Wealth Advisors LLC now owns 935 shares of the company's stock valued at $28,000 after purchasing an additional 507 shares during the period. Meeder Asset Management Inc. acquired a new stake in Cinemark in the 3rd quarter valued at approximately $63,000. Smartleaf Asset Management LLC raised its stake in Cinemark by 20.1% during the 3rd quarter. Smartleaf Asset Management LLC now owns 3,027 shares of the company's stock valued at $83,000 after acquiring an additional 506 shares in the last quarter. Leonteq Securities AG acquired a new position in Cinemark during the 4th quarter worth $83,000. Finally, GAMMA Investing LLC boosted its position in Cinemark by 51.8% during the 4th quarter. GAMMA Investing LLC now owns 4,022 shares of the company's stock worth $93,000 after acquiring an additional 1,372 shares during the period.

About Cinemark

Cinemark Holdings, Inc NYSE: CNK is a leading theatrical exhibitor that acquires, develops and operates motion picture theatres under the Cinemark® brand in the United States and Latin America. The company's core business involves the presentation of first-run feature films coupled with an array of in‐theatre services, including concessions, premium auditoriums and loyalty programs. Cinemark's exhibition portfolio encompasses both corporate‐owned and franchised complexes, offering moviegoers a range of experiences from standard screens to large‐format halls.

The company's product offerings extend beyond ticket sales to include an assortment of concession items, such as popcorn, fountain beverages, candy and specialty snacks, as well as bar and lounge concepts in select locations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.